​

Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?

OverviewForecastRevenueFinancialsChart

Jasper Therapeutics Ownership Summary

Jasper Therapeutics is owned by 89.37% institutional investors, 1.27% insiders, and 9.36% retail investors. Greenline partners is the largest institutional shareholder, holding 0% of JSPR shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.

JSPR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockJasper Therapeutics89.37%1.27%9.36%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Greenline partners---
Marshall wace, llp---
Opaleye management---
Metlife investment management---
Jane street group---
Boothbay fund management---
Palo alto investors lp---
Samsara biocapital---
Creative planning---
Woodline partners lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Greenline partners---
Marshall wace, llp---
Opaleye management---
Metlife investment management---
Jane street group---
Boothbay fund management---
Palo alto investors lp---
Samsara biocapital---
Creative planning---
Woodline partners lp---

Top Buyers

HolderShares% AssetsChange
Nisa investment advisors---53.00
Greenline partners---100.00
Creative planning---1.03K
Metlife investment management---6.87K
Entrypoint capital---10.43K

Top Sellers

HolderShares% AssetsChange
Braidwell lp---714.66K
Samsara biocapital---584.64K
Opaleye management---400.00K
Great point partners---322.38K
Russell investments group---247.27K

Sold Out

HolderChange
Nisa investment advisors-53.00
Greenline partners-100.00
Creative planning-1.03K
Metlife investment management-6.87K
Entrypoint capital-10.43K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202570-24.73%13,034,411-16.69%890.78%32-38.46%2335.29%
Dec 31, 20249210.84%15,645,9346.60%1071.12%5115.91%17-10.53%
Sep 30, 20248318.57%14,676,9540.82%971.04%44-19111.11%
Jun 30, 2024709.38%14,557,01311.80%971.02%4425.71%9-62.50%
Mar 31, 20246464.10%13,020,873-82.64%972.12%35105.88%24166.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Polar Capital Healthcare Opports Inc581.54K3.85%-
T. Rowe Price Small-Cap Value438.89K2.92%-94.00
Vanguard Total Stock Mkt Idx Inv421.12K2.80%19.90K
Franklin Biotechnology Discv A(acc)USD339.25K2.26%-
iShares Russell 2000 ETF291.73K1.94%144.00
HBM Healthcare Investments AG Ord250.00K1.67%-
T. Rowe Price U.S. SC Value Eq Tr-D245.81K1.64%217.41K
T. Rowe Price U.S. SC Value Eq Tr-Z245.81K1.64%217.41K
Fidelity Select Health Care208.04K1.39%208.04K
Franklin Biotechnology Discovery A195.44K1.30%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 12, 2024Mahal Jeetinder Singh Chief Operating OfficerSell$19.90K
Sep 12, 2024Mahal Jeetinder Singh Chief Operating OfficerSell$19.10K
Jun 12, 2024Mahal Jeetinder Singh Chief Operating OfficerSell$21.74K
Mar 12, 2024Mahal Jeetinder Singh Chief Operating OfficerSell$23.79K
Feb 08, 2024Carlyle Group Inc. Former 10% OwnerBuy$2.46M

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q4-1
2024 Q3-1
2024 Q2-1

JSPR Ownership FAQ

Who Owns Jasper Therapeutics?

Jasper Therapeutics shareholders are primarily institutional investors at 89.37%, followed by 1.27% insiders and 9.36% retail investors. The average institutional ownership in Jasper Therapeutics's industry, Biotech Stocks , is 63.97%, which Jasper Therapeutics exceeds.

Who owns the most shares of Jasper Therapeutics?

Jasper Therapeutics’s largest shareholders are Greenline partners (0 shares, 0%), Marshall wace, llp (0 shares, 0%), and Opaleye management (0 shares, 0%). Together, they hold 0% of Jasper Therapeutics’s total shares outstanding.

Does Blackrock own Jasper Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Jasper Therapeutics.

Who is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested?

Greenline partners is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Jasper Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Jasper Therapeutics shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Jasper Therapeutics shares, with 3.85% of its total shares outstanding invested in 581.54K Jasper Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools